SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    C. Brightling, As strong as an OX or as weak as a kitten?, Clinical & Experimental Allergy, 2014, 44, 1
  2. 2
    Joseph R. Arron, Jeffrey M. Harris, Genomic Biomarkers for Pharmaceutical Development, 2014,

    CrossRef

  3. 3
    A. Mari, M. Antonietta Ciardiello, G. Passalacqua, H. Vliagoftis, A. J. Wardlaw, M Wickman, Developments in the field of allergy in 2012 through the eyes of Clinical & Experimental Allergy, Clinical & Experimental Allergy, 2013, 43, 12
  4. 4
    K. Somasundaram, J. Ball, Medical emergencies: pulmonary embolism and acute severe asthma, Anaesthesia, 2013, 68,
  5. 5
    David M. Lang, Multimorbidity: The New Normal, Annals of the American Thoracic Society, 2013, 10, 5, 491

    CrossRef

  6. 6
    Joseph R. Arron, David F. Choy, Heleen Scheerens, John G. Matthews, Noninvasive Biomarkers That Predict Treatment Benefit from Biologic Therapies in Asthma, Annals of the American Thoracic Society, 2013, 10, Supplement, S206

    CrossRef

  7. 7
    Marijke Amelink, Jantina C. de Groot, Selma B. de Nijs, Rene Lutter, Aeilko H. Zwinderman, Peter J. Sterk, Anneke ten Brinke, Elisabeth H. Bel, Severe adult-onset asthma: A distinct phenotype, Journal of Allergy and Clinical Immunology, 2013, 132, 2, 336

    CrossRef

  8. 8
    Sevim Bavbek, Turkish Thoracic Society 16th Annual Congress: while I breathe, I hope, Expert Review of Respiratory Medicine, 2013, 7, 5, 447

    CrossRef

  9. 9
    Joseph R. Arron, Heleen Scheerens, John G. Matthews, Immunopharmacology, 2013,

    CrossRef

  10. 10
    You Sook Cho, Definition of Severe Refractory Asthma, Korean Journal of Medicine, 2012, 83, 4, 417

    CrossRef

  11. 11
    Young-Hee Nam, Soo-Keol Lee, Management of Severe Refractory Asthma, Korean Journal of Medicine, 2012, 83, 4, 438

    CrossRef